🎤 Excited to share that our CEO, Brian Feth, will be presenting at Meeting on the Mesa 2025! Brian will highlight how Xcell Biosciences’ AVATAR™ platform is reshaping cell therapy manufacturing by creating conditions that better reflect the tumor microenvironment. By enabling more potent and persistent therapies, we’re helping the field address some of the toughest challenges in treating solid tumors. 📅 October 6 at 11:00 AM 📍 Frank Lloyd Wright Ballroom F Don’t miss the session—join us in exploring how innovation in manufacturing can accelerate the path to patients. #MeetingOnTheMesa #CellTherapy #GeneTherapy #CGT #AVATAR #CellManufacturing #Biotech
xcellbio’s Post
More from this author
-
PX-478, an HIF-1a inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer
-
Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
-
Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment.
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development